Summary: A thyroid suppression test is suggested which relies on the change in concentration of serum thyroxine as the index of thyroid response to the administration of triiodothyronine. The test has been carried out in 16 healthy volunteers and in 27 patients referred for routine suppression tests. This index appears to be sensitive and safe and results in a reduction in the required dosage of triiodothyronine. The test can be carried out in fewer patient-visits than the commonly used suppression test; moreover, in remote areas the patient need not attend the specialist centre because the course of triiodoth.yronine can be given (and the serum samples obtained) locally, the samples then being sent to the appropriate laboratory for assay. Introduction Though Greer and Smith (1954) showed that a comparison of the 24-hour neck uptake of a tracer dose of radioiodine before and after a course of desiccated thyroid afforded a useful method of distinguishing the presence of thyroid autonomy, the suppression test as now normally applied is based on the method of Werner and Spooner (1955) , who used triiodothyronine (T,) -as the suppressing agent. Variants from the original report consist in the dosage regimen selected and in the particular measurements used to assess thyroid handling of an iodide tracer. This paper reports a study in which the selected index of thyroid response to the administration of a course of T3 is the total serum concentration of thyroxine (T.).
Materials and Methods
The serum thyroxine was measured and the 13I1 uptake into the thyroid was determined as indicated previously 
Results
The inital serum T4 concentration in all the volunteers was in the normal range, which in our laboratory is taken to be 45-115 ng./ml. Fig. 2 concentration as an index of suppressibility could be a more sensitive index than indices based on tracer uptake measurements.
The two other patients in whom discordant results were obtained were both women. One was a young woman with a " hot nodule " whose uptake did not suppress but whose T4 came just within the tentative limit of normal suppression. The other showed the converse: normal suppression of uptake but no suppression of T4 concentration. She had a goitre considered as likely to be a lymphocytic thyroiditis. The goitre decreased in size dramatically as a result of treatment with thyroxine.
Since the use of the serum T4 concentration as an index of thyroid suppressibility avoids the in-vivo use of radioactive iodine it also avoids the disadvantages inherent in iodide tracer studies. Allusion has been made to these in the preceding paper . It also appears that a satisfactory separation of those whose thyroid gland suppresses from those whose gland does not can be obtained with a threeday to five-day course of no more than 80 jig. daily of T3. Thyroid Suppression Test-Williams et al.
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Though further studies are necessary to determine the optimum dosage 'regimen to maximize the diagnostic efficiency of the test, it would appear that the use of the thyroid functional index suggested would minimize the possible adverse effects of T3 administration in the presence of thyrotoxicosis.
We would like to thank our colleagues who allowed us to carry out studies on them and the members of the consultant staff of the Middlesex Hospital who referred patients to us for investigation and so enabled this work to be carried out.
Introduction
Tetramisole is a synthetic compound which has been found to possess anthelmintic properties. Chemically it is the hydrochloride of 2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazole.
The racemic mixture of tetramisole has been found to be effective at low dose levels against a variety of nematodes.
Clinical trials carried out in South America (Mesquita and Daher, 1966; Nascimento Filha et al., 1966) and South Africa (Seftel and Heinz, 1968) showed that it is highly effective and se in the treatment of ascariasis in man.
Further studies in rats, mice, sheep, and cattle have shown that levamisole, the laevo-isomer of tetramisole, is about twice as active as the racemic mixture, and, depending on the parasite, several times more active than the dextro-isomer (Rohrbacher et al., 1967 ; Bullock et al., 1968 . In rats and mice the LD,0 values for the two isomers and for racemic tetramisole proved almost identical (Raeymaekers et al., 1967) . These findings indicated that levamisole would be as effective as the racemic mixture at a lower dosage, and that the safety margin could correspondingly be increased. It was therefore decided to conduct a clinical trial to assess the therapeutic and toxic effects of levamisole in the treatment of ascariasis in children.
Patients and Methods The trial was carried out in two stages. The first stage was to determine the efficacy and safety of levamisole in the treatment of ascariasis in children, and the second stage was to compare its effects with those of piperazine, at present the drug of choice in treating ascariasis.
Children whose stools showed ascaris ova on faecal smear examination were selected for the trial from those admitted to two wards of the Lady Ridgeway Hospital, Colombo. The stools were examined with the faecal smear technique (Beaver, 1961) , a recognized method of carrying out ascaris ova counts (W.H.O., 1964) .
In the first stage of the trial the effects of levamisole were determined in 111 patients, many of whom had symptoms suggestive of ascariasis, such as vomiting, diarrhoea, and abdominal pain. Four of them were drowsy and dehydrated, 22 showed evidence of malnutrition, and 12 were severely anaemic with haemoglobin levels below 7 4 g./100 ml. Eightyone were between 2 and 9 years of age, 13 less than 2 years, and 17 over 9 years. Liver function tests were carried out before and after treatment on 14 patients, and haemoglobin estimations on 20 patients selected randomly, to determine possible hepatic and haemopoietic toxicity.
In the second stage of the trial 100 children were randomly allocated to two groups, one group being treated with levamisole and the other with piperazine. At the end of the trial there were 50 patients in each group. Table I compares the two treatment groups with regard to sex and age. Table II shows the similarity of the presenting symptoms in the patients in the two groups before treatment. 
